Laboratorio Farmaceutico Erfo S.p.A. (ERFO.MI)
- Previous Close
1.2050 - Open
1.2250 - Bid 1.2100 x --
- Ask 1.2350 x --
- Day's Range
1.2100 - 1.2350 - 52 Week Range
0.8800 - 1.7000 - Volume
10,000 - Avg. Volume
8,774 - Market Cap (intraday)
10.594M - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
30.88 - EPS (TTM)
0.0400 - Earnings Date --
- Forward Dividend & Yield 0.06 (5.18%)
- Ex-Dividend Date Jul 1, 2024
- 1y Target Est
2.08
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.
www.erfo.it41
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ERFO.MI
更多內容Performance Overview: ERFO.MI
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is FTSEMIB.MI (FTSEMIB.MI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
比較: ERFO.MI
選擇以關鍵表現數據分析類似公司；最多可選擇 4 個股份。
Statistics: ERFO.MI
更多內容Valuation Measures
Market Cap
10.59M
Enterprise Value
10.66M
Trailing P/E
29.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.74
Price/Book (mrq)
1.40
Enterprise Value/Revenue
1.77
Enterprise Value/EBITDA
8.58
Financial Highlights
Profitability and Income Statement
Profit Margin
5.85%
Return on Assets (ttm)
3.30%
Return on Equity (ttm)
4.57%
Revenue (ttm)
6.03M
Net Income Avi to Common (ttm)
352.82k
Diluted EPS (ttm)
0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
376.13k
Total Debt/Equity (mrq)
5.05%
Levered Free Cash Flow (ttm)
865.91k